Create Alert
Watchlist

Solara Active Pharma Sciences

₹590.50
-7.85 (1.31%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
602.80
Prev. Close
598.35
Volume
98,377
Total traded value
5.81 Cr
Upper Circuit
708.60
Lower Circuit
472.40

Fundamentals

Market Cap₹2,622Cr
ROE0.51%
P/E Ratio(TTM)333.33
EPS(TTM)1.77
P/B Ratio1.71
Dividend Yield0.00%
Industry P/E33.29
Book Value344.61
Debt to Equity0.51
Face Value10
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Solara Active Pharma

Solara Active Pharma Sciences Limited is a trusted leader in the pharmaceutical sector, committed to delivering high-quality API products and providing superior healthcare solutions. The company's vision is to rank among the top 10 pure-play global API companies that create significant value for partners and stakeholders while protecting human life and the environment. Its mission is to be a customer-centric organization that delivers high-quality Active Pharmaceutical Ingredients, ensuring it consistently meets and exceeds market expectations through innovation and efficiency. Alongside its main business, the company also specializes in comprehensive Contract Research and Manufacturing Services (CRAMS) to identify and capitalize on new growth opportunities. With an impressive product portfolio, the company currently offers over 60 commercial APIs to a loyal customer base across many countries worldwide. Its operations are extensive, with a global presence across key markets including North America, Europe, and Japan, supported by six API manufacturing facilities.;
Parent OrganisationSolara Active Pharma Sciences Limited
Managing DirectorMr. Poorvank Purohit
Founded2017
NSE SymbolSOLARA

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
42.01%
Retail And Others
41.72%
Foreign Institutions
13.58%
Other Domestic Institutions
1.51%
Mutual Funds
1.18%

Top Mutual Funds Invested(1)

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.25
Emcure Pharmaceuticals
NA
(0.00%)
33.30
Wockhardt
NA
(0.00%)
-427.29
Cohance Lifesciences
NA
(0.00%)
65.51
2025
5
Nov
Quarterly Result
Release date
25
Jul
Quarterly Result
Release date
15
May
Annual Result
Release date
24
Jan
Quarterly Result
Release date
2024
21
Oct
Quarterly Result
Release date
22
Jul
Quarterly Result
Release date
29
May
Result
Release date

15
May
Rights Entitlement
Ex date
1:3
Ratio

1 rights eligible for every 3 existing shares held
Ratio1:3
Offer price₹375.00
Ex date15 May ‘24
Record date15 May ‘24
Announcement date9 May ‘24

9
May
Rights Entitlement
Announced
1:3
Ratio

1 rights eligible for every 3 existing shares held
Ratio1:3
Offer price₹375.00
Ex date15 May ‘24
Record date15 May ‘24
Announcement date9 May ‘24
Events calendar
View upcoming events in other stocks